NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Stay updated with breaking news from Development Pipeline Objectives. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Evaluation of NBTXR3 for global registration in priority head and neck cancer pathway proceeds with the first European patient randomized in global phase III NANORAY-312 study; US and Asia site